Contineum Therapeutics (CTNM) Q3 2025 Earnings

5AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.62
-0.55
-0.47
-0.4

Details

Expected EPS
-0.440386
Actual EPS
-0.62
Surprise EPS
-0.18
Surprise Percent
+40.79%

Description

Contineum Therapeutics (CTNM) has reported earnings of -0.62 per share for Q3 2025.

0 Comments

Share your thoughts